Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pump Therapy Management (Keeping Patients On The Pump)

View through CrossRef
Preview patients are “fine-tuned” when the basal rate(s) and bolus doses, determined using the insulin-to-carbohydrate ratio (ICR) and correction factor (CF), yield results within the patient’s target glycemic levels most of the time. The patient may need to collect information (e.g., self-monitoring blood glucose [SMBG] or continuous glucose monitoring [CGM] records, carbohydrate intake, and bolus doses) to assist the clinician in evaluating their status, although modern pump software downloads can record much of this information if the patient is using a bolus calculator. Use of nonbranded multisystem platforms can often integrate CGM and pump data that are not already synced. A limitation of downloaded pump CGM data is in reviewing food choices in terms of accuracy of entered carbohydrate counts and the presence of noncarbohydrate factors that affect glycemia, such as fat content. Careful monitoring and detailed food recordkeeping in the early stages of pump therapy, although tedious, can be beneficial, especially if the patient is not doing well. The management of pump therapy requires assessing, evaluating, and modifying the basal rates, ICR(s), CF, and how the patient uses the pump. When making changes with the patient, explain why and how adjustments are made. Your explanations will help increase the patient’s understanding of the basics of pump therapy and build confidence in their ability to identify problems and practice appropriate self-management pump skills.
American Diabetes Association
Title: Pump Therapy Management (Keeping Patients On The Pump)
Description:
Preview patients are “fine-tuned” when the basal rate(s) and bolus doses, determined using the insulin-to-carbohydrate ratio (ICR) and correction factor (CF), yield results within the patient’s target glycemic levels most of the time.
The patient may need to collect information (e.
g.
, self-monitoring blood glucose [SMBG] or continuous glucose monitoring [CGM] records, carbohydrate intake, and bolus doses) to assist the clinician in evaluating their status, although modern pump software downloads can record much of this information if the patient is using a bolus calculator.
Use of nonbranded multisystem platforms can often integrate CGM and pump data that are not already synced.
A limitation of downloaded pump CGM data is in reviewing food choices in terms of accuracy of entered carbohydrate counts and the presence of noncarbohydrate factors that affect glycemia, such as fat content.
Careful monitoring and detailed food recordkeeping in the early stages of pump therapy, although tedious, can be beneficial, especially if the patient is not doing well.
The management of pump therapy requires assessing, evaluating, and modifying the basal rates, ICR(s), CF, and how the patient uses the pump.
When making changes with the patient, explain why and how adjustments are made.
Your explanations will help increase the patient’s understanding of the basics of pump therapy and build confidence in their ability to identify problems and practice appropriate self-management pump skills.

Related Results

The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
PROTOTYPE POMPA APUNG
PROTOTYPE POMPA APUNG
ABSTRACT Floating pump is a water pump than can flat and adapt to the level of water surface. This water pump is solution of the problem happens because of the significant increas...
Investigation of vortex in pump sump by V3V measurements
Investigation of vortex in pump sump by V3V measurements
Abstract The aims, scope and conclusions of the paper must be in a self-contained abstract of a single paragraph with 60-120 words. The abstract must be informative ...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract Introduction Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Presentation and Management of Cervical Thoracic Duct Cyst: A Systematic Review of the Literature
Presentation and Management of Cervical Thoracic Duct Cyst: A Systematic Review of the Literature
Abstract Introduction Thoracic duct cysts are an uncommon phenomenon, especially within the cervical region. Due to its limited reported cases, very little is known about its etiol...

Back to Top